Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score
Condition(s) studied
Investigational drug(s) / intervention(s)
Tranexamic Acid (TXA): To see if nebulised TXA is better to control blood loss in functional Endoscopic sinus surgery
Tranexamic Acid: To see if intravenous TXA is better to control blood loss in functional Endoscopic sinus surgery
Study summary
The aim of this study is to investigate the effect of preoperative administration of intravenous or nebulized tranexamic acid on surgical field, blood loss, anesthetic consumption and hemodynamics of patients undergoing FESS.
Primary outcome Modena Bleeding Score (MBS) assessing surgical field Secondary outcome
1. Patient hemodynamics.
2. Anesthetic consumption, Extra doses of fentanyl and propofol and sevoflurane\>2
3. Postoperative complications: including any adverse effects to TXA e.g.nausea, vomiting, any visual disturbances, fits, and any thrombotic manifestation.
Eligibility
Primary outcome measure(s)
- Modena Bleeding Score- assessing surgical field — Baseline
* No bleeding -\>1. * Bleeding easily controlled by suctioning, washing, or packing without any significant modification or slowing of surgical procedure-\>2. * Bleeding slowing surgical procedure-\>3. * Most of the maneuvers dedicated to bleeding control -\>4. * Bleeding that prevents every surgical procedure except those dedicated to bleeding control-\>5.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Main building, Assiut University Hospitals | Asyut | Egypt | Recruiting |
More Assiut University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06725732 on ClinicalTrials.gov ↗ ← All trials in Egypt